ENDO HEALTH SOLUTIONS INC | 26,195 Euro | -0,545 -2,04 % | |
| WKN: 940110 ISIN: US29264F2056 Ticker-Symbol: EPV | München | 21.05.13 | 08:25 Uhr |
Branche PharmaAktienmarkt NASDAQ BiotechS&P MidCap 400 |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 13.05. | Setback for Endo Health on Opana ER | - | Zacks | |
| 13.05. | Shares of Endo Pharmaceuticals Down on Above Average Volume, Moving Against Trend | 1 | SmarTrend | |
| 13.05. | Analysis of Relative Performance in the Healthcare Sector for Shares of Endo Pharmaceuticals | 2 | SmarTrend | |
| 13.05. | Shares of Endo Pharmaceuticals Under Pressure, Down 5.1% | - | SmarTrend | |
| 11.05. | UPDATE 1-FDA allows generic forms of Endo Health's Opana ER painkiller | 1 | Reuters.com | |
| 11.05. | FDA allows generic forms of Endo Health's Opana ER painkiller | - | Reuters.com | |
| 10.05. | BRIEF-Endo Health down 2.8 percent in extended trade | 1 | Reuters.com | |
| 10.05. | Watch for Endo Pharmaceuticals to Potentially Rebound After Falling 5.28% Yesterday | 1 | SmarTrend | |
| 10.05. | Endo Health Solutions Responds to FDA's Denial of OPANA ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone | 62 | PR Newswire | |
| MALVERN, Pa., May 10, 2013 /PRNewswire/ --Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has denied a Citizen Petition filed by its subsidiary... Mehr lesen zu: Endo Health Solutions Responds to FDA's Denial of OPANA ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone | ||||
| 10.05. | Possible Bearish Inside Day Candle Pattern Detected for Endo Pharmaceuticals | - | SmarTrend | |
| 09.05. | Bearish Moving Average Cross by Endo Pharmaceuticals | - | SmarTrend | |
| 08.05. | Downgrade Alert for Endo Pharmaceuticals | 1 | SmarTrend | |
| 07.05. | ENDO HEALTH SOLUTIONS INC. - 10-Q, Quaterly Report | - | SEC Filings | |
| 07.05. | Endo Health Solutions Management Discusses Q1 2013 Results - Earnings Call Transcript | 1 | Seeking Alpha | |
| 07.05. | Endo Health Solutions Swings To Profit In Q1, Meets View; Backs FY13 View | 48 | AFX News | |
| WASHINGTON (dpa-AFX) - Endo Health Solutions Inc.,(ENDP), a provider of
specialty healthcare solutions, reversed to a profit in the first quarter from
loss last year, while adjusted earnings... Mehr lesen zu: Endo Health Solutions Swings To Profit In Q1, Meets View; Backs FY13 View | ||||
| 07.05. | Endo Health turns 1Q profit, affirms 2013 forecast | - | Yahoo-USA | |
| 07.05. | ENDO HEALTH SOLUTIONS INC. - 8-K, Current Report | - | SEC Filings | |
| 07.05. | Endo Health Swings to First-Quarter Profit On Strong Generic Drug Sales | - | Euroinvestor | |
| 07.05. | Endo Pharma trifft im im a... | 152 | BörseGo | |
| Endo Pharma trifft im im abgelaufenen Geschäftsquartal mit einem Gewinn je Aktie von $1,09 die Analystenschätzungen. Umsatz mit $709 Mio unter den Erwartungen von $740 Mio.
(© BörseGo AG 2013 - Autor:... Mehr lesen zu: Endo Pharma trifft im im a... | ||||
| 07.05. | Endo Reports First Quarter Financial Results | 20 | PR Newswire | |
| MALVERN, Pa., May7, 2013 /PRNewswire/ --
Total quarterly revenues of $709 million, increased by 3 percent versus prior year.
First quarter reported diluted (GAAP) EPS of $0.14.
First quarter... Mehr lesen zu: Endo Reports First Quarter Financial Results | ||||
